Hyperthermic intraperitoneal chemotherapy for recurrent epithelial ovarian cancer

Hyperthermic intraperitoneal chemotherapy for recurrent epithelial ovarian cancer

Background: To investigate outcomes and morbidity of patients undergoing secondary cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in recurrent ovarian cancer. Materials and methods: Between April 2014 and January 2019, a total of 51 recurrent ovarian cancer patient...

Full description

Bibliographic Details
Main Authors: Wei-Chun Chen, Huei-Jean Huang, Lan-Yan Yang, Yu-Bin Pan, Kuan-Gen Huang, Cheng-Tao Lin, Min-Yu Chen, Yun-Hsin Tang, Ting-Chang Chang, Chyong-Huey Lai, Hung-Hsueh Chou
Format: Article
Language:English
Published: Elsevier 2022-10-01
Series:Biomedical Journal
Subjects:
Hyperthermic intraperitoneal chemotherapy
HIPEC
Ovarian cancer
Recurrent
Cytoreductive surgery
Online Access:http://www.sciencedirect.com/science/article/pii/S2319417021001372

Internet

http://www.sciencedirect.com/science/article/pii/S2319417021001372

Similar Items